Targeting a Genetic Mutation Associated with Canine Bladder Cancer
Researchers will explore drug treatments that target a genetic mutation associated with bladder cancer in dogs.
Researchers will explore drug treatments that target a genetic mutation associated with bladder cancer in dogs.
Researchers will assess the value of a genetic prognostic tool to assist with treatment decisions for dogs with diffuse large B-cell lymphoma.
Researchers will assess how well specific chemotherapy drugs work as an adjunct therapy for dogs recovering from bone cancer surgery.
Researchers will investigate a new treatment for feline oral cancers, using small molecular inhibitors.
Researchers will develop advanced DNA-based techniques for characterizing feline soft-tissue sarcomas, which may help veterinarians provide a more comprehensive diagnosis and improve their ability to choose the most appropriate clinical management strategies for these cancers.
Researchers will investigate the role of a signaling pathway in the progression of bone cancer in dogs and evaluate its potential as a new therapeutic target to help treat this disease.
Researchers will investigate targeted therapies for the treatment of B-cell lymphoma in dogs.